Literature DB >> 26537222

Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15.

Richard G Pebody1, Helen K Green, Nick Andrews, Nicola L Boddington, Hongxin Zhao, Ivelina Yonova, Joanna Ellis, Sophia Steinberger, Matthew Donati, Alex J Elliot, Helen E Hughes, Sameera Pathirannehelage, David Mullett, Gillian E Smith, Simon de Lusignan, Maria Zambon.   

Abstract

The 2014/15 influenza season was the second season of roll-out of a live attenuated influenza vaccine (LAIV) programme for healthy children in England. During this season, besides offering LAIV to all two to four year olds, several areas piloted vaccination of primary (4-11 years) and secondary (11-13 years) age children. Influenza A(H3N2) circulated, with strains genetically and antigenically distinct from the 2014/15 A(H3N2) vaccine strain, followed by a drifted B strain. We assessed the overall and indirect impact of vaccinating school age children, comparing cumulative disease incidence in targeted and non-targeted age groups in vaccine pilot to non-pilot areas. Uptake levels were 56.8% and 49.8% in primary and secondary school pilot areas respectively. In primary school age pilot areas, cumulative primary care influenza-like consultation, emergency department respiratory attendance, respiratory swab positivity, hospitalisation and excess respiratory mortality were consistently lower in targeted and non-targeted age groups, though less for adults and more severe end-points, compared with non-pilot areas. There was no significant reduction for excess all-cause mortality. Little impact was seen in secondary school age pilot only areas compared with non-pilot areas. Vaccination of healthy primary school age children resulted in population-level impact despite circulation of drifted A and B influenza strains.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26537222     DOI: 10.2807/1560-7917.ES.2015.20.39.30029

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  42 in total

1.  Syndromic Surveillance Revolution? Public Health Benefits of Modernizing the Emergency Care Patient Health Record in England.

Authors:  Helen E Hughes; Thomas C Hughes; Aaron Haile; Gillian E Smith; Brian McCloskey; Alex J Elliot
Journal:  Public Health Rep       Date:  2017 Jul/Aug       Impact factor: 2.792

2.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

3.  Extension of influenza immunization program to children in England - Future plans.

Authors:  Pauline MacDonald
Journal:  Hum Vaccin Immunother       Date:  2016-10-02       Impact factor: 3.452

4.  Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.

Authors:  Laetitia Gerlier; Mark Lamotte; Sofia Dos Santos Mendes; Oliver Damm; Markus Schwehm; Martin Eichner
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

5.  Influenza vaccination: in the UK and across Europe.

Authors:  Simon de Lusignan; Ana Correa; Joanna Ellis; Richard Pebody
Journal:  Br J Gen Pract       Date:  2016-09       Impact factor: 5.386

6.  Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season.

Authors:  Jin Hyang Kim; Margarita Mishina; Jessie R Chung; Kelly Stefano Cole; Mary Patricia Nowalk; Judith M Martin; Sarah Spencer; Brendan Flannery; Richard K Zimmerman; Suryaprakash Sambhara
Journal:  J Infect Dis       Date:  2016-08-17       Impact factor: 5.226

7.  RCGP Research and Surveillance Centre Annual Report 2014-2015: disparities in presentations to primary care.

Authors:  Simon de Lusignan; Ana Correa; Sameera Pathirannehelage; Rachel Byford; Ivelina Yonova; Alex J Elliot; Theresa Lamagni; Gayatri Amirthalingam; Richard Pebody; Gillian Smith; Simon Jones; Imran Rafi
Journal:  Br J Gen Pract       Date:  2016-12-19       Impact factor: 5.386

8.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

9.  Sustainability of school-located influenza vaccination programs in Florida.

Authors:  Cuc H Tran; Joe Brew; Nicholas Johnson; Kathleen A Ryan; Brittany Martin; Catherine Cornett; Brad Caron; R Paul Duncan; Parker A Small; Paul D Myers; J Glenn Morris
Journal:  Vaccine       Date:  2016-04-25       Impact factor: 3.641

10.  Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study.

Authors:  Cheryl Cohen; Jackie Kleynhans; Jocelyn Moyes; Meredith L McMorrow; Florette K Treurnicht; Orienka Hellferscee; Azwifarwi Mathunjwa; Anne von Gottberg; Nicole Wolter; Neil A Martinson; Kathleen Kahn; Limakatso Lebina; Katlego Mothlaoleng; Floidy Wafawanaka; Francesc Xavier Gómez-Olivé; Thulisa Mkhencele; Angela Mathee; Stuart Piketh; Brigitte Language; Stefano Tempia
Journal:  Lancet Glob Health       Date:  2021-06       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.